Avoiding Overtreatment of Ductal Carcinoma in situ.

Breast Neoplasms / diagnosis Carcinoma, Intraductal, Noninfiltrating / diagnosis Combined Modality Therapy / adverse effects Disease Management Disease Progression Early Detection of Cancer Female Humans Medical Overuse / prevention & control Prognosis Risk Treatment Outcome
breast cancer ductal carcinoma in situ overdiagnosis overtreatment screening

Journal

Trends in cancer
ISSN: 2405-8025
Titre abrégé: Trends Cancer
Pays: United States
ID NLM: 101665956

Informations de publication

Date de publication:
07 2019
Historique:
received: 29 03 2019
revised: 13 05 2019
accepted: 14 05 2019
entrez: 18 7 2019
pubmed: 18 7 2019
medline: 1 7 2020
Statut: ppublish

Résumé

Ductal carcinoma in situ (DCIS), a precursor to invasive breast cancer (IBC), represents 25% of all breast neoplasms. Most are harmless, but some progress to IBC. Yet, almost all DCIS are treated. Learning how to distinguish harmless from hazardous DCIS will save many women with harmless DCIS the burden of overtreatment.

Identifiants

DOI: 10.1016/j.trecan.2019.05.005 PMID: 31311652
pubmed: 31311652
pii: S2405-8033(19)30096-2
doi: 10.1016/j.trecan.2019.05.005
pii:
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-393

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Carolien L van der Borden (CL)

Division of Molecular Pathology, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Saskia Stoffers (S)

Division of Molecular Pathology, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Esther H Lips (EH)

Division of Molecular Pathology, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Jelle Wesseling (J)

Division of Molecular Pathology, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Division of Diagnostic Oncology, Department of Pathology, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. Electronic address: j.wesseling@nki.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › Avoiding Overtreatment of Ductal Carcinoma in situ.
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Tumeurs canalaires, lobulaires et médullaires › Carcinome intracanalaire non infiltrant › Avoiding Overtreatment of Ductal Carcinoma in situ.
questionsmedicales.fr › Thérapeutique › Association thérapeutique › Avoiding Overtreatment of Ductal Carcinoma in situ.
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Prise en charge de la maladie › Avoiding Overtreatment of Ductal Carcinoma in situ.
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Évolution de la maladie › Avoiding Overtreatment of Ductal Carcinoma in situ.
questionsmedicales.fr › Diagnostic › Diagnostic précoce › Dépistage précoce du cancer › Avoiding Overtreatment of Ductal Carcinoma in situ.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Avoiding Overtreatment of Ductal Carcinoma in situ.
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Attitude envers la santé › Mésusage des services de santé › Surmédicalisation › Avoiding Overtreatment of Ductal Carcinoma in situ.
questionsmedicales.fr › Diagnostic › Pronostic › Avoiding Overtreatment of Ductal Carcinoma in situ.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Avoiding Overtreatment of Ductal Carcinoma in situ.
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Avoiding Overtreatment of Ductal Carcinoma in situ.